Though treatment for opioid use disorders with medications (buprenorphine or naltrexone provided in primary care, or methadone from an Opioid Treatment Program) has been shown to be effective, the majority of patients with OUDs are never treated with medications, and most primary care practices do not offer buprenorphine treatment. This trial seeks to compare a collaborative care model to “Usual Primary Care” for management of OUDs in primary care across multiple health care systems.
CTN Protocol ID:
Katharine Bradley, M.D., M.P.H.
Principle Investigator, Senior Scientist Senior Investigator
Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Ste. 1600
Seattle, WA 98101